Worse Survival in Breast Cancer Among Women with Recent Childbirth: Results from a Swedish Population-Based Register Study

2003 ◽  
Vol 4 (4) ◽  
pp. 280-285 ◽  
Author(s):  
Anna Bladström ◽  
Harald Anderson ◽  
Håkan Olsson



2009 ◽  
Vol 98 (3) ◽  
pp. 561-566 ◽  
Author(s):  
K Ekholm Selling ◽  
J Carstensen ◽  
O Finnström ◽  
A Josefsson ◽  
G Sydsjö


2021 ◽  
Vol 11 ◽  
Author(s):  
Martin Maripuu ◽  
Marie Bendix ◽  
Louise Öhlund ◽  
Micael Widerström ◽  
Ursula Werneke

Background: Individuals with severe mental disorder (SMD) have a higher risk of somatic comorbidity and mortality than the rest of the population. We set up a population-based study to assess whether individuals with SMD had a higher risk of death associated with a COVID-19 infection (COVID-19 associated death) than individuals without SMD.Methods: Exploratory analysis with a cross-sectional design in the framework of a population-based register study covering the entire Swedish population. The Swedish Board for Health and Welfare (Socialstyrelsen) provided anonymized tabulated summary data for further analysis. We compared numbers of COVID-19 associated death in individuals with SMD (cases) and without SMD (controls). We calculated the odds ratio (OR) for the whole sample and by age group and four comorbidities, namely diabetes, cardiovascular disease, hypertension, chronic lung disease.Results: The sample comprised of 7,923,859 individuals, 103,999 with SMD and 7,819,860 controls. There were 130 (0.1%) COVID-19 associated deaths in the SMD group and 4,945 (0.06%) in the control group, corresponding to an OR of 1.98 (CI 1.66-2.35; p < 0.001). The odds were 4-fold for the age groups between 60 and 79 years and 1.5-fold for cardiovascular diseases. Individuals with SMD without any of the risk factors under study had 3-fold odds of COVID-19 associated death.Conclusion: Our preliminary results identify individuals with SMD as a further group at increased risk of COVID-19 associated death. In regard to comorbidities, future studies should explore the potential confounding or mediation role in the relationship between SMD and COVID-19 associated deaths.





1998 ◽  
Vol 34 (13) ◽  
pp. 2068-2075 ◽  
Author(s):  
P. Karlsson ◽  
E. Holmberg ◽  
A. Samuelsson ◽  
K.-A. Johansson ◽  
A. Wallgren


BMC Medicine ◽  
2017 ◽  
Vol 15 (1) ◽  
Author(s):  
Haomin Yang ◽  
Judith S. Brand ◽  
Jingmei Li ◽  
Jonas F. Ludvigsson ◽  
Emilio Ugalde-Morales ◽  
...  


BMJ Open ◽  
2017 ◽  
Vol 7 (3) ◽  
pp. e014968 ◽  
Author(s):  
Hannah L Brooke ◽  
Gunilla Ringbäck Weitoft ◽  
Mats Talbäck ◽  
Maria Feychting ◽  
Rickard Ljung




Cancers ◽  
2020 ◽  
Vol 13 (1) ◽  
pp. 95
Author(s):  
Vincenzo de Giorgi ◽  
Luciana Trane ◽  
Federico Venturi ◽  
Flavia Silvestri ◽  
Federica Scarfì ◽  
...  

We read the paper by Katsarelias et al. with great interest, regarding the effect of beta-adrenergic blocking agents on cutaneous melanoma [1]. However, the study presents some methodology biases that do not allow us to support the authors’ conclusions. The paper suffers from the unification and evaluation of multiple registries, which do not provide essential data for any of the targets for research. Unlike studies in the literature [...]



Sign in / Sign up

Export Citation Format

Share Document